Free Trial

Carisma Therapeutics (CARM) SEC Filings & 10K Form

Carisma Therapeutics logo
$0.23 +0.00 (+0.88%)
Closing price 08/28/2025 03:59 PM Eastern
Extended Trading
$0.24 +0.01 (+4.39%)
As of 08/28/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Carisma Therapeutics SEC Filings

DateFilerForm TypeView
08/21/2025
4:57 PM
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics (Subject)
HealthCap VII, L.P. (Filed by)
Form SCHEDULE 13D/A
07/31/2025
8:06 AM
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form DEFA14A
07/21/2025
5:12 AM
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
06/24/2025
8:06 PM
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics (Subject)
Form 425
06/23/2025
4:15 PM
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics (Subject)
Form 425
06/23/2025
4:15 PM
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics (Subject)
Form 425
06/23/2025
6:41 AM
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
6:42 AM
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics (Subject)
Form 425
05/13/2025
3:43 PM
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/16/2025
3:30 PM
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
3:53 PM
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/31/2025
3:32 PM
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/13/2025
6:00 AM
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
7:35 AM
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:35 AM
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:39 AM
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
3:30 PM
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Cheng Sohanya Roshan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/01/2024
3:31 PM
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Cheng Sohanya Roshan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:30 PM
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:49 PM
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CARM) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners